课题基金 / 基金详情

MULTICENTER TRIAL OF MEVINOLIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

MULTICENTER TRIAL OF MEVINOLIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Mevinolin 在原发性高胆固醇血症患者中的多中心试验
批准号：
6116918
负责人：
D ROGER ILLINGWORTH
金额：
$3.13万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6116918
关键词：
antihypercholesterolemic agent clinical research clinical trials drug screening /evaluation human subject human therapy evaluation hypercholesterolemia lovastatin metabolism disorder chemotherapy

项目摘要

项目成果

D ROGER ILLINGWORTH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is a multicenter trial evaluating the role of lovastatin as a hypolipidemic agent in patients with familial hypercholesterolemia. Twenty patients will be enrolled in this study at our institution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of simvastatin on postprandial hyperlipidemia
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
海外基金